MBT
DGX icon

Monroe Bank & Trust’s Quest Diagnostics DGX Stock Holding History

Monroe Bank & Trust’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-131
Closed -$15K – 147
2017
Q2 		$15K Hold
131
– – 0.01% 214
2017
Q1 		$13K Hold
131
– – ﹤0.01% 227
2016
Q4 		$12K Buy
+131
New +$11.3K ﹤0.01% 236
2015
Q3 		– Sell
-310
Closed -$22K – 318
2015
Q2 		$22K Hold
310
– – 0.01% 218
2015
Q1 		$24K Buy
+310
New +$22.2K 0.01% 215

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Monroe Bank & Trust's DGX Position: Q3 2017 in Review

Monroe Bank & Trust sold out of Quest Diagnostics (DGX) in Q3 2017, closing a stake of 131 shares — an estimated $15K sold.

Monroe Bank & Trust first reported a position in DGX in Q1 2015 and held it in 5 quarters. The position peaked at $24K in Q1 2015. 616 funds tracked by Wall St. Rank hold DGX as of Q3 2017.

  • Monroe Bank & Trust reported no remaining Quest Diagnostics position as of Q3 2017 after selling out during the quarter.
  • Monroe Bank & Trust sold 131 Quest Diagnostics shares in Q3 2017, an estimated $15K.
  • Monroe Bank & Trust first reported a position in Quest Diagnostics in Q1 2015 and held it in 5 quarters.
  • Monroe Bank & Trust's Quest Diagnostics position peaked at $24K in Q1 2015.
  • 616 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2017.

Based on Monroe Bank & Trust's 13F filing for Q3 2017, filed 8 Nov 2017.